Amarin Corp. Plc (AMRN)
12.35
-0.37
(-2.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.38
+0.02
(+0.20%)
After-Hours: 20:00
Amarin Max Drawdown (5Y) : 98.07% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.07% |
| August 31, 2026 | 98.07% |
| July 31, 2026 | 98.07% |
| June 30, 2026 | 98.07% |
| May 31, 2026 | 98.07% |
| April 30, 2026 | 98.07% |
| March 31, 2026 | 98.07% |
| February 28, 2026 | 98.07% |
| January 31, 2026 | 98.07% |
| December 31, 2025 | 98.07% |
| November 30, 2025 | 98.07% |
| October 31, 2025 | 98.07% |
| September 30, 2025 | 98.07% |
| August 31, 2025 | 98.07% |
| July 31, 2025 | 98.07% |
| June 30, 2025 | 98.07% |
| May 31, 2025 | 98.07% |
| April 30, 2025 | 98.07% |
| March 31, 2025 | 98.07% |
| February 28, 2025 | 98.07% |
| January 31, 2025 | 98.07% |
| December 31, 2024 | 98.07% |
| November 30, 2024 | 98.07% |
| October 31, 2024 | 97.65% |
| September 30, 2024 | 97.65% |
| Date | Value |
|---|---|
| August 31, 2024 | 97.49% |
| July 31, 2024 | 97.40% |
| June 30, 2024 | 97.40% |
| May 31, 2024 | 97.26% |
| April 30, 2024 | 97.26% |
| March 31, 2024 | 97.26% |
| February 29, 2024 | 97.26% |
| January 31, 2024 | 97.26% |
| December 31, 2023 | 97.26% |
| November 30, 2023 | 97.26% |
| October 31, 2023 | 97.16% |
| September 30, 2023 | 96.50% |
| August 31, 2023 | 95.81% |
| July 31, 2023 | 95.56% |
| June 30, 2023 | 95.56% |
| May 31, 2023 | 95.56% |
| April 30, 2023 | 95.56% |
| March 31, 2023 | 95.56% |
| February 28, 2023 | 95.56% |
| January 31, 2023 | 95.56% |
| December 31, 2022 | 95.56% |
| November 30, 2022 | 95.56% |
| October 31, 2022 | 95.56% |
| September 30, 2022 | 95.48% |
| August 31, 2022 | 95.32% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Neurocrine Biosciences, Inc. | 46.39% |
| Alkermes Plc | 68.08% |
| Liquidia Corp. | 92.71% |
| Akari Therapeutics Plc | 99.83% |
| DBV Technologies SA | 98.19% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -45.17 |
| Beta (5Y) | 0.7616 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 61.77% |
| Historical Sharpe Ratio (5Y) | -0.6079 |
| Historical Sortino (5Y) | -1.011 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.94% |